This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Bed Bath & Beyond (BBBY) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Bed Bath & Beyond (BBBY) closed at $13.15 in the latest trading session, marking a -1.87% move from the prior day.
Zacks Market Edge Highlights: Bed Bath & Beyond, L Brands, Fossil, Chipotle and Chevron
by Zacks Equity Research
Zacks Market Edge Highlights: Bed Bath & Beyond, L Brands, Fossil, Chipotle and Chevron
Buy and Hold Investors Must Learn to Do This
by Tracey Ryniec
Buy it and forget about it sounds good in theory but it takes more than that to be a successful buy and hold investor.
Bed Bath & Beyond Performs Dismally: Soft Margins to Blame?
by Zacks Equity Research
Bed Bath & Beyond (BBBY) is struggling with issues like strained margins and soft comparable store sales over the past few quarters now.
Oil & Gas, Bed Bath & Beyond, Apple, Sony, PayPal Holdings highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Oil & Gas, Bed Bath & Beyond, Apple, Sony, PayPal Holdings highlighted as Zacks Bull and Bear of the Day
Bear of the Day: Bed Bath & Beyond (BBBY)
by Tracey Ryniec
With shares at 5-year lows, is it a value stock or a trap?
New Strong Sell Stocks for October 1st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Company News For Sep 28, 2018
by Zacks Equity Research
Companies in the news are: BBBY, MKC, CCL and CAG
Guide to CRISPR Stocks & Latest Apple, Fed, GDP News | Free Lunch
by Ryan McQueeney
Ryan McQueeney highlights the Fed's latest rate hike sentiment and new revisions to GDP growth estimates. He also recaps Bed Bath & Beyond's earnings results and touches on analyst research related to Apple. Later, he is joined by Zacks' biotech guru, Kevin Cook, to chat about CRISPR stocks and how to invest in the developing science.
Economic Data Deluge
by Zacks Equity Research
Economic Data Deluge
Bed Bath & Beyond (BBBY) Down 14% on Q2 Earnings & Sales Miss
by Zacks Equity Research
Bed Bath & Beyond (BBBY) posts dismal second-quarter fiscal 2018 results. Also, the company trims its outlook for the fiscal year.
Oasis of Economic Data, Plus BBBY Sells Off
by Mark Vickery
Jobless Claims, Durable Goods orders, revised Q2 GDP and a new Trade Balance all fortify forward-looking market perspectives.
Bed Bath & Beyond (BBBY) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Bed Bath & Beyond (BBBY) delivered earnings and revenue surprises of -26.53% and -0.59%, respectively, for the quarter ended August 2018. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include: Verso, Bed Bath, American Airlines, Avis Budget and Dillard's
by Zacks Equity Research
Zacks.com featured highlights include: Verso, Bed Bath, American Airlines, Avis Budget and Dillard's
Is the Options Market Predicting a Spike in Bed Bath & Beyond (BBBY) Stock?
by Zacks Equity Research
Investors need to pay close attention to Bed Bath & Beyond (BBBY) stock based on the movements in the options market lately.
Recent Analyst Upgrades Make These 5 Stocks Attractive
by Zacks Equity Research
Given their thorough understanding of the stock market, it is prudent to pay heed to broker advice while designing a winning portfolio.
What to Expect From Bed Bath & Beyond (BBBY) in Q2 Earnings?
by Zacks Equity Research
Bed Bath & Beyond's (BBBY) dismal margins trend is concerning. Nevertheless, its solid strategies and transformation efforts are likely to boost quarterly results.
Bed Bath & Beyond (BBBY) Q2 Earnings Preview: What to Know Ahead of the Release
by Zacks Equity Research
Bed Bath & Beyond (BBBY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bed Bath & Beyond (BBBY) Surges: Stock Moves 6% Higher
by Zacks Equity Research
Bed Bath & Beyond (BBBY) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Bed Bath & Beyond Down 34% in a Year: Is a Turnaround Likely?
by Zacks Equity Research
Bed Bath & Beyond (BBBY) is witnessing contraction in margins for the last eight quarters. Though comps remain soft, the company's store-growth initiatives are encouraging.
Should Value Investors Pick Bed Bath & Beyond (BBBY) Stock?
by Zacks Equity Research
Let's see if Bed Bath & Beyond Inc. (BBBY) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Company News For Jun 29, 2018
by Zacks Equity Research
Companies in the news are: BBBY,MKC,ACN,PRGS
Bed Bath & Beyond (BBBY) Down Despite Q1 Earnings & Sales Beat
by Zacks Equity Research
Bed Bath & Beyond (BBBY) performs impressively in first-quarter fiscal 2018. However, the company's shares decline due to fall in comparable sales, and lower gross and operating margins.
Options Traders Expect Huge Moves in Bed Bath & Beyond (BBBY) Stock
by Zacks Equity Research
Investors in Bed Bath & Beyond (BBBY) need to pay close attention to the stock based on moves in the options market lately.
Bed Bath & Beyond (BBBY) Stock Falls on Earnings Beat, Revenues In- Line
by Nimah Quadri
Bed Bath & Beyond (BBBY) just released its latest quarterly results, posting earnings of 32 cents per share and revenues of $2.8 billion